Cases
Nevro Corporation (NVRO)
Securities Class Action
Overview
Overview
- Date:
- 11/7/2018
- Company Name:
- Nevro Corporation
- Stock Symbol:
- NVRO
- Class Period:
- FROM 1/8/2018 TO 7/12/2018
- Status:
- Closed/Complete
NEW YORK, November 7, 2018 – Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Nevro Corporation (NYSE: NVRO).
On August 23, 2018, a complaint was filed alleging that between January 8, 2018 and July 12, 2018, defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and the proprietary nature of the company’s principal products. Specifically, defendants allegedly made false and/or misleading statements and/or failed to disclose that: (1) Nevro had engaged in a fraudulent scheme by using protected confidential and proprietary trade secrets and stolen documents from its competitors to develop and enhance the company’s Senza systems; (2) as a result, the company’s Senza systems were not “novel” or “proprietary;” (3) these practices caused the company to be vulnerable to increased litigation expenses and adverse legal and regulatory action; (4) as a result, Nevro’s U.S. sales growth was not sustainable; and (5) as a result of the foregoing, defendants’ statements about Nevro’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
If you are a long term stockholder of Nevro, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On August 23, 2018, a complaint was filed alleging that between January 8, 2018 and July 12, 2018, defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and the proprietary nature of the company’s principal products. Specifically, defendants allegedly made false and/or misleading statements and/or failed to disclose that: (1) Nevro had engaged in a fraudulent scheme by using protected confidential and proprietary trade secrets and stolen documents from its competitors to develop and enhance the company’s Senza systems; (2) as a result, the company’s Senza systems were not “novel” or “proprietary;” (3) these practices caused the company to be vulnerable to increased litigation expenses and adverse legal and regulatory action; (4) as a result, Nevro’s U.S. sales growth was not sustainable; and (5) as a result of the foregoing, defendants’ statements about Nevro’s business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.
If you are a long term stockholder of Nevro, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.